pvp001
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 25, 2018 (NCT03594331)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- GlutenINHIBITOR
Gluten inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03701555 | Phase 1 | Jun 19, 2018 | Anaheim Clinical Trials, PvP Biologics, Inc. |
| NCT03594331 | Phase 1 | May 25, 2018 | PvP Biologics, Inc., University of Michigan |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PvP Biologics, Inc. | For profit | 2 | 1 | 1 | 2018 |
| Anaheim Clinical Trials | For profit | 1 | 0 | 1 | 2018 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1